Femara (letrozole) for early-stage breast cancer

More women will be taking Femara (letrozole) for early-stage breast cancer...after taking tamoxifen for 5 years.

Tamoxifen is the standard of care for treating postmenopausal women with hormone-receptor-positive breast cancer.

Taking tamoxifen for 5 years can reduce the risk of recurrent breast cancer by 47% and improve survival.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote